Cellectar Biosciences to Present at the 37th Annual Roth Conference


FLORHAM PARK, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that members of its management team will present an overview of the company at the upcoming 37th Annual Roth Conference. Details are as follows:

Read the original post:
Cellectar Biosciences to Present at the 37th Annual Roth Conference

Related Posts